It’s all about the relationship: The caregiver experience of supporting a person with advanced cancer going through an LSD microdosing trial
Fiona Cottam, Alesha Wells, Cerys Clayden, Lisa Reynolds
Palliative & Supportive Care January 1, 2026 DOI: 10.1017/s1478951526101977 (opens in new tab) via OpenAlex
Summary
AI-generated from the abstractParticipating in trials of psychedelic-assisted meaning-centered psychotherapy (MCP) may provide hope for both cancer patients and their caregivers. Because the well-being of patients and caregivers is interconnected, the authors argue that caregivers should be included alongside patients in these clinical trials.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Population | Caregivers of advanced cancer patients in an LSD microdosing trial |
| Keywords | Clinical trial Psychotherapist Terminal cancer Cancer treatment Family medicine |
| Key finding | Argues that caregivers should be included alongside patients in psychedelic-assisted therapy trials for cancer-related distress because of the bidirectional relationship in well-being between cancer dyads. |
Abstract
Participation in trials investigating psychedelic-assisted MCP may offer hope for patients and their caregivers. Given the bidirectional relationship in wellbeing between cancer dyads, caregivers should be included alongside patients in such trials.